QC
NEO icon

Quadrature Capital’s NeoGenomics NEO Stock Holding History

Quadrature Capital’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$380K Buy
+26,051
New +$251K ﹤0.01% 1121
2026
Q1 		– Sell
-30,894
Closed -$363K – 1693
2025
Q4 		$363K Buy
+30,894
New +$333K ﹤0.01% 783

Other funds holding NEO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
GF
Greenhouse Funds Baltimore, Maryland $1.96B AUM 36.47% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

Quadrature Capital's NEO Position: Q2 2026 in Review

Quadrature Capital opened a new position in NeoGenomics (NEO) in Q2 2026: 26,051 shares worth $380K. The stake represents ﹤0.01% of the portfolio and ranks #1121 among its holdings. This is a return to the name: Quadrature Capital previously reported a position in NEO as recently as Q4 2025.

Quadrature Capital first reported a position in NEO in Q4 2025 and has held it in 2 quarters since. 266 funds tracked by Wall St. Rank hold NEO as of Q2 2026.

  • Quadrature Capital held 26,051 shares of NeoGenomics worth $380K as of Q2 2026.
  • NeoGenomics was a new Quadrature Capital position in Q2 2026.
  • NeoGenomics made up ﹤0.01% of Quadrature Capital's portfolio in Q2 2026, its #1121 holding.
  • Quadrature Capital first reported a position in NeoGenomics in Q4 2025 and has held it in 2 quarters since.
  • 266 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.

Based on Quadrature Capital's 13F filing for Q2 2026, filed 7 Aug 2026.